Before loading with tumour lysate, DCs were characterized by flow cytometry to analyse the expression of MHC class I and II molecules, costimulatory molecules (CD86, CD80, CD40), and markers associated with maturation (CD83, CCR7, PD-L1). The gene discussed is CD274; the disease is neoplasm.